Clinical Trials on Ureterocele
Total 1 results
-
Handan First HospitalRecruiting
Sponsors and Collaborators
- Horizon Pharma USA, Inc.
- Universidad de Ciencias Empresariales y Sociales
- Immunis, Inc.
- Öğr. Gör. Ali GÜZEL
- Meander Medisch Centrum
- Piotr Chlosta
- For Ever Fabien
- The Adam Practice, Dorset
- Colorado State University Extension-La Plata County
- Y.S.P. Industries (M) Sdn. Bhd, Menara LGB, Taman Tun Dr Ismail, 60000 Kuala Lumpur, Malaysia
- DILEK SAYIK
- NED University of Engineering and Technology
- Fundación Salutia
- Iuppa Industriale S.r.l.
- Frankfurter Institut für Klinische Krebsforschung IKF GmbH
- Neurological Research Center
- Grin Eye Care
- Maria de Lourdes de Sousa Maia, MD
- Research Center for Clinical Neuroimmunology and Neuroscience Basel
- National Cancer Imaging Translational Accelerator
- View Full List
Medical Conditions
- Otitis
- Stage III Lung Small Cell Carcinoma AJCC v7
- Headache, Intractable
- Lymphocyte Subsets in Women of Child-bearing Age
- Groin Node
- Trypanosoma Brucei Rhodesiense; Infection
- Megalencephaly-capillary Malformation Polymicrogyria Syndrome (MCAP)
- Oral Sulfate Solution
- Hyperosmolality
- Alcohol Abuse in Pregnancy
- Neurological Diseases, Heart or Respiratory Failure,
- Raynaud Secondary to Other Autoimmune Disease
- Allogeneic, Hematopoietic Cell Transplant (HCT)
- Multiple Conditions
- Health Care Worker
- Nasal High-frequency Oscillatory Ventilation
- Rhinitis, Allergic, Nonseasonal
- Orthopaedic Injuries
- Cancer of Lung, Kidney or Liver
- Normal Sinus Rhythm With 2 or 3° AV or BBB Block
- View Full List
Drug Interventions
- Ciprodex (R)
- Irinotecan
- [18F]-JNJ-64413739
- ATV/r plus ABC/3TC
- Valette
- Voriconazole low dose
- POLAT-001
- TPN171H 10mg
- Benzocaine Gel
- Multiple PET/MRI with Gallium-68 labeled PSMA-HBED-CC
- OROS methylphenidate hydrochloride
- Fumaric acids
- Cyclophosphamide
- 1 mg of transdermal estradiol daily and 10mg of oral MPA
- AZD1305
- Drug A (Blinded Drug)
- Dexamethasone
- Budigalimab
- Schedule Finding Triplet: Combination of NKTR-214+ nivolumab+ ipilimumab
- Stillen® Tab
- View Full List
CROs by country
- Contract Research Organizations in Bahrain
- Contract Research Organizations in Burkina Faso
- Contract Research Organizations in Cambodia
- Contract Research Organizations in Jamaica
- Contract Research Organizations in Kenya
- Contract Research Organizations in Liberia
- Contract Research Organizations in Malta
- Contract Research Organizations in Oman
- Contract Research Organizations in Philippines
- Contract Research Organizations in Slovakia
- Contract Research Organizations in South Africa
- Contract Research Organizations in Sweden
- Contract Research Organizations in Zambia
- CRO list by country